<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Summary of schedule, dose, route, and preferred site for routinely recommended immunizations for children &lt;18 years of age in the United States</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Summary of schedule, dose, route, and preferred site for routinely recommended immunizations for children &lt;18 years of age in the United States</h1>
<div class="graphic"><div class="figure"><div class="ttl">Summary of schedule, dose, route, and preferred site for routinely recommended immunizations for children &lt;18 years of age in the United States</div><div class="cntnt"><table cellspacing="0"><colgroup span="5" width="20%"></colgroup> <tbody> <tr> <td class="subtitle1">Vaccine</td> <td class="subtitle1">Recommended ages for routine administration</td> <td class="subtitle1">Dose</td> <td class="subtitle1">Route</td> <td class="subtitle1">Preferred site</td> </tr> <tr> <td class="subtitle2_left" colspan="5">Inactivated vaccines and/or toxoids</td> </tr> <tr> <td class="indent1">Diphtheria, tetanus, acellular pertussis</td> <td> <ul> <li>2 months</li> <li>4 months</li> <li>6 months</li> <li>15 through 18 months</li> <li>4 through 6 years</li> </ul> </td> <td> <ul> <li>0.5 mL</li> </ul> </td> <td>IM</td> <td> <ul> <li>&lt;3 years: Anterolateral thigh (vastus lateralis)</li> <li>≥3 years: Deltoid</li> </ul> </td> </tr> <tr> <td class="indent1"><em>Haemophilus influenzae</em> type b</td> <td> <ul> <li>2 months</li> <li>4 months</li> <li>6 months*</li> <li>12 through 15 months</li> </ul> </td> <td> <ul> <li>0.5 mL</li> </ul> </td> <td>IM</td> <td> <ul> <li>Anterolateral thigh</li> </ul> </td> </tr> <tr> <td class="indent1">Hepatitis A</td> <td> <ul> <li>Two doses, at least 6 months apart, between 12 and 24 months</li> </ul> </td> <td> <ul> <li>0.5 mL</li> </ul> </td> <td>IM</td> <td> <ul> <li>Anterolateral thigh</li> </ul> </td> </tr> <tr> <td class="indent1">Hepatitis B<sup>¶</sup></td> <td> <ul> <li>Within 24 hours of birth</li> <li>1 to 2 months</li> <li>6 to 12 months</li> </ul> </td> <td> <ul> <li>0.5 mL</li> </ul> </td> <td>IM</td> <td> <ul> <li>Anterolateral thigh</li> </ul> </td> </tr> <tr> <td class="indent1">Human papillomavirus<sup>Δ</sup></td> <td> <ul> <li>11 through 12 years: Two doses separated by at least six months</li> </ul> </td> <td> <ul> <li>0.5 mL</li> </ul> </td> <td>IM</td> <td> <ul> <li>Deltoid</li> </ul> </td> </tr> <tr> <td class="indent1">Influenza, inactivated</td> <td> <ul> <li>One or two doses annually<sup>◊</sup> for children ≥6 months of age</li> </ul> </td> <td> <ul> <li>Child 6 through 35 months: 0.25 ( Afluria) or 0.5 mL (Fluarix, FluLaval, or Fluzone)</li> <li>Child ≥36 months: 0.5 mL</li> </ul> </td> <td>IM</td> <td> <ul> <li>&lt;3 years: Anterolateral thigh</li> <li>≥3 years: Deltoid</li> </ul> </td> </tr> <tr> <td class="indent1">Meningococcal conjugate vaccine, quadrivalent</td> <td> <ul> <li>11 through 12 years</li> <li>16 years</li> </ul> </td> <td> <ul> <li>0.5 mL</li> </ul> </td> <td>IM</td> <td> <ul> <li>Deltoid</li> </ul> </td> </tr> <tr> <td class="indent1">Meningococcal serogroup B<sup>§</sup></td> <td> <ul> <li>16 to 18 years</li> </ul> </td> <td> <ul> <li>0.5 mL</li> </ul> </td> <td>IM</td> <td> <ul> <li>Deltoid</li> </ul> </td> </tr> <tr> <td class="indent1">Pneumococcal conjugate vaccine</td> <td> <ul> <li>2 months</li> <li>4 months</li> <li>6 months</li> <li>12 through 15 months</li> </ul> </td> <td> <ul> <li>0.5 mL</li> </ul> </td> <td>IM</td> <td> <ul> <li>Anterolateral thigh</li> </ul> </td> </tr> <tr> <td class="indent1">Poliovirus, inactivated</td> <td> <ul> <li>2 months</li> <li>4 months</li> <li>6 through 18 months</li> <li>4 through 6 years</li> </ul> </td> <td> <ul> <li>0.5 mL</li> </ul> </td> <td>IM or subcutaneous</td> <td> <ul> <li>IM: <ul> <li>&lt;3 years: Anterolateral thigh (vastus lateralis)</li> <li>≥3 years: Deltoid</li> </ul> </li> <li>Subcutaneous: <ul> <li>&lt;12 months: Fatty tissue over anterolateral thigh</li> <li>≥12 months: Fatty tissue over upper-outer triceps<sup>¥</sup></li> </ul> </li> </ul> </td> </tr> <tr> <td class="indent1">Tetanus toxoid, reduced diphtheria toxoid, acellular pertussis</td> <td> <ul> <li>11 through 12 years</li> </ul> </td> <td> <ul> <li>0.5 mL</li> </ul> </td> <td>IM</td> <td> <ul> <li>Deltoid</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="5">Inactivated combination vaccines</td> </tr> <tr> <td class="indent1">DTaP-HepB-IPV vaccine (Pediarix)</td> <td> <ul> <li>2 months</li> <li>4 months</li> <li>6 months</li> </ul> </td> <td> <ul> <li>0.5 mL</li> </ul> </td> <td>IM</td> <td> <ul> <li>Anterolateral thigh</li> </ul> </td> </tr> <tr> <td class="indent1">DTaP-IPV/Hib vaccine (Pentacel)</td> <td> <ul> <li>2 months</li> <li>4 months</li> <li>6 months</li> <li>15 through 18 months</li> </ul> </td> <td> <ul> <li>0.5 mL</li> </ul> </td> <td>IM</td> <td> <ul> <li>Anterolateral thigh</li> </ul> </td> </tr> <tr> <td class="indent1">DTaP-IPV-Hib-HepB vaccine (Vaxelis)</td> <td> <ul> <li>2 months</li> <li>4 months</li> <li>6 months</li> </ul> </td> <td> <ul> <li>0.5 mL</li> </ul> </td> <td>IM</td> <td> <ul> <li>Anterolateral thigh</li> </ul> </td> </tr> <tr> <td class="indent1">DTaP-IPV vaccine (Kinrix, Quadricel)</td> <td> <ul> <li>4 through 6 years</li> </ul> </td> <td> <ul> <li>0.5 mL</li> </ul> </td> <td>IM</td> <td> <ul> <li>Deltoid</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="5">Live attenuated vaccines</td> </tr> <tr> <td class="indent1">Influenza, live attenuated</td> <td> <ul> <li>One or two doses annually<sup>◊</sup> for children ≥2 years of age</li> </ul> </td> <td> <ul> <li>0.2 mL (0.1 mL in each nostril)</li> </ul> </td> <td>Intranasal</td> <td>–</td> </tr> <tr> <td class="indent1">Measles, mumps, and rubella</td> <td> <ul> <li>12 through 15 months</li> <li>4 through 6 years</li> </ul> </td> <td> <ul> <li>0.5 mL</li> </ul> </td> <td>Subcutaneous or IM (M-M-R II vaccine only)</td> <td> <ul> <li>Subcutaneous: Fatty tissue over upper-outer triceps<sup>¥</sup></li> <li>IM: <ul> <li>&lt;3 years: Anterolateral thigh (vastus lateralis)</li> <li>≥3 years: Deltoid</li> </ul> </li> </ul> </td> </tr> <tr> <td class="indent1" rowspan="2">Rotavirus</td> <td> <ul> <li>RV1: <ul> <li>2 months</li> <li>4 months</li> </ul> </li> </ul> </td> <td> <ul> <li>1 mL</li> </ul> </td> <td>Orally</td> <td>–</td> </tr> <tr> <td> <ul> <li>RV5: <ul> <li>2 months</li> <li>4 months</li> <li>6 months</li> </ul> </li> </ul> </td> <td> <ul> <li>2 mL</li> </ul> </td> <td>Orally</td> <td>–</td> </tr> <tr> <td class="indent1">Varicella</td> <td> <ul> <li>12 through 15 months</li> <li>4 through 6 years</li> </ul> </td> <td> <ul> <li>0.5 mL</li> </ul> </td> <td>Subcutaneous or IM</td> <td> <ul> <li>Subcutaneous: Fatty tissue over upper-outer triceps<sup>¥</sup></li> <li>IM: <ul> <li>&lt;3 years: Anterolateral thigh</li> <li>≥3 years: Deltoid</li> </ul> </li> </ul> </td> </tr> <tr> <td class="indent1">Dengue<sup>‡</sup></td> <td> <ul> <li>9 through 16 years</li> <li>3 doses separated by 6 months</li> </ul> </td> <td> <ul> <li>0.5 mL</li> </ul> </td> <td>Subcutaneous</td> <td> <ul> <li>Fatty tissue over upper-outer triceps<sup>¥</sup></li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="5">Live attenuated combination vaccines</td> </tr> <tr> <td class="indent1"> <p>MMRV vaccine (ProQuad)</p> Available only for children ≤12 years</td> <td> <ul> <li>12 through 15 months<sup>†</sup></li> <li>4 through 6 years</li> </ul> </td> <td> <ul> <li>0.5 mL</li> </ul> </td> <td>Subcutaneous or IM</td> <td> <ul> <li>Subcutaneous: Fatty tissue over upper-outer triceps<sup>¥</sup></li> <li>IM: <ul> <li>&lt;3 years: Anterolateral thigh</li> <li>≥3 years: Deltoid</li> </ul> </li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="5">Viral component vaccines</td> </tr> <tr> <td class="indent1">COVID-19 vaccines</td> <td colspan="4"> <ul> <li>Refer to UpToDate content on COVID-19 vaccines.</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_lgnd">This table summarizes recommendations for routine childhood immunizations in the United States.</div><div class="graphic_footnotes"><p>IM: intramuscular;
    DTaP: diphtheria, tetanus, acellular pertussis;
    HepB: hepatitis B;
    IPV: inactivated poliovirus;
    Hib: <em>H. influenzae</em> type b;
    Hib-MenCY: Hib-meningococcal serogroups CY combination vaccine;
    RV1: attenuated human rotavirus vaccine;
    RV5: pentavalent human-bovine rotavirus reassortant vaccine;
    MMRV: measles, mumps, rubella, and varicella; COVID-19: coronavirus disease 2019; MMR: measles, mumps, and rubella.</p>
<p>* The 6 month dose may not be necessary, depending upon vaccine formulation.</p>
<p>¶ The recommended schedule varies with birth weight and hepatitis B surface antigen status of the mother. Refer to UpToDate content on hepatitis B vaccines for infants for details.</p>
<p>Δ If the human papillomavirus series is initiated at age ≥15 years, three doses should be administered: The second dose is recommended one to two months after the first dose, and the third dose is recommended six months after the first dose.</p>
<p>◊ Refer to UpToDate content on seasonal influenza vaccines for children for additional information.</p>
<p>§ Meningococcal serogroup B vaccines are not routinely recommended for adolescents who are not at increased risk for meningococcal disease. However, they may be given to adolescents and young adults age 16 through 23 years.</p>
<p>¥ The fatty tissue over the upper-outer triceps is the preferred site. The fatty tissue over the anterolateral thigh is an acceptable alternative.</p>
<p>‡ For children who live in dengue endemic United States territories and sovereign states in free association with the United States (American Samoa, Federated States of Micronesia, Republic of Marshall Islands, Republic of Palau, Puerto Rico, United States Virgin Islands) <strong>and</strong> have laboratory confirmation of previous Dengue infection. Refer to the <a href="https://www.cdc.gov/mmwr/volumes/70/rr/rr7006a1.htm?s_cid=rr7006a1_w" target="_blank">ACIP recommendations</a> and <a href="https://www.cdc.gov/dengue/vaccine/hcp/index.html" target="_blank">www.cdc.gov/dengue/vaccine/hcp/index.html</a>.</p>
    † Administration MMRV as the first dose of measles-containing vaccine at age 12 through 15 months has been associated with an increased risk of febrile seizures. The <a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5903a1.htm" target="_open">Centers for Disease Control and Prevention</a> and American Academy of Pediatrics suggest that MMR and varicella vaccine be administered as separate injections at age 12 through 15 months unless the parents/caregivers have a preference for MMRV. Refer to UpToDate content on MMR and varicella vaccination for children for additional details</div><div id="graphicVersion">Graphic 114641 Version 15.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
